<DOC>
	<DOC>NCT02839096</DOC>
	<brief_summary>The investigators will randomize women diagnosed with anemia in the mid-trimester of pregnancy to once or twice daily iron supplementation</brief_summary>
	<brief_title>Once Versus Twice Daily Iron Supplementation in Pregnant Women</brief_title>
	<detailed_description>Women defined as having iron deficiency anemia based on a low hemoglobin as defined by the American College of Obstetrics and Gynecology and a low serum ferritin, in the absence of hemoglobinopathy, will be randomized to ferrous sulfate 325mg PO daily or PO twice daily.</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<criteria>Singleton gestation Iron deficiency anemia as defined by a Hgb of less than 11mg/dL in the first and 3rd trimester and 10.5mg/dL in the 2nd trimester and a serum ferritin of less than 15ug/mL. In accordance with ACOG guidelines, the Hgb cutoff will be reduced by 0.8mg/dL in African American women. In accordance with the standard of care, African American women and those with an MCV on their routine screening CBC of less than 70 will require a hemoglobin electrophoresis to exclude hemoglobinopathy prior to enrollment. Multiple gestation Maternal hemoglobinopathy or hemochromatosis, Irritable bowel disease or irritable bowel syndrome History of bariatric surgery or extensive bowel surgery Individuals already receiving iron supplementation aside from prenatal vitamins.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>